Page 36 - Pharma Sector News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Indian pharma exports touch record $24.44 bn in pandemic year; see 18.07% growth North America is the largest exporting region for India with more than 34 per cent share. Country wise exports to USA, Canada and Mexico recorded growth of 12.6 per cent, 30 per cent and 21.4 per cent respectively Joe C Mathew | April 17, 2021 | Updated 16:18 IST Pharma exports see 18.07% growth Indian pharmaceutical exports have registered a record growth in the pandemic year (2020-21), bucking the global trend of 1-2 per cent negative growth in 2020. As per the quick estimates of the Department of Commerce, d...

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : This product is a monthly auto renewal product. Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. ...

Capital expenditure in industrial sectors is expected to rise 45-55 per cent in financial year 2021-22 as the economy gains from a government's scheme to boost productivity, said a report by Crisil Research on Tuesday. The India Outlook Report expects gross domestic product (GDP) growth to be at 11 per cent in fiscal 2022, after an estimated 8 per cent contraction this fiscal. The next fiscal, like the current, will have a low base “optical” growth in the first half and a rebound in the second. The capex rise in pharmaceuticals, chemicals, textiles, cement, auto and ancillary, metals a...

Domestic pharma market is witnessing a slow recovery, with growth crawling to 1.1 per cent in February after a 4.5 per cent growth in the previous month. December, in fact, was a strong month — the industry clocked an 8.5 per cent growth. In February, the key therapy areas of the Indian Pharmaceutical Market (IPM) witnessed slow growth — while cardiac grew 7.3 per cent compared to 8.8 per cent in the month before, anti-diabetic reported 4.3 per cent growth. Sheetal Sapale, president, marketing for AIOCD AWACS, a market research firm, said as anti-infectives and respiratory therapies ha...

Prime Minister Narendra Modi on Friday said the production-linked incentive (PLI) scheme would lead to output worth $520 billion in India in the next five years, while industry asked for clarity on implementation across sectors. Modi said the government was working at every level to promote industry through measures like ease of doing business, reducing the compliance burden, creating multi-modal infrastructure to reduce logistics costs, and constructing district-level export hubs. “Our effort is to reduce over 6,000 compliance burdens (for industry),” he said. The prime minister was s...